Table 1.
Non-ccRCC patient characteristics
| Characteristic | Total (N = 101) |
|
|---|---|---|
| No. of patients | % | |
| Gender | ||
| Male | 55 | 54 |
| Female | 46 | 46 |
| Stage | ||
| 1 | 54 | 53 |
| 2 | 19 | 19 |
| 3 | 18 | 18 |
| 4 | 9 | 9 |
| Unknown | 1 | 1 |
| Fuhrman grade | ||
| I/II | 53 | 52.4 |
| III | 38 | 37.6 |
| IV | 9 | 9 |
| Unknown | 1 | 1 |
| Histology | ||
| Chromophobe | 36 | 36 |
| Papillary | 50 | 49 |
| Translocation | 10 | 10 |
| Collecting duct carcinomas | 5 | 5 |
| Metastatic disease | ||
| No | 78 | 77.2 |
| Yes | 23 | 22.8 |
| PD-L1 expression in tumor cells membrane | ||
| <5% (negative) | 90 | 89.1 |
| ≥5% (positive) | 11 | 10.9 |
| PD-L1 expression in tumor-infiltrating mononuclear cells (TIMC) | ||
| Score = 0 (negative) | 44 | 43.6 |
| Score > 0 (positive) | 57 | 56.4 |
| Median | Min, max | |
| Age at Dx (years) | 59 | 24–81 |
| Tumor size (cm) | 4.7 | 0.6–30 |